DK0756489T3 - Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette - Google Patents

Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette

Info

Publication number
DK0756489T3
DK0756489T3 DK95920275T DK95920275T DK0756489T3 DK 0756489 T3 DK0756489 T3 DK 0756489T3 DK 95920275 T DK95920275 T DK 95920275T DK 95920275 T DK95920275 T DK 95920275T DK 0756489 T3 DK0756489 T3 DK 0756489T3
Authority
DK
Denmark
Prior art keywords
pct
preparation
cyclosporin
sec
composition
Prior art date
Application number
DK95920275T
Other languages
English (en)
Inventor
Hyun Soo Kim
Jae Yoon Choi
Hye Weon Lee
Young Keun Park
Sung Wook Choi
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of DK0756489T3 publication Critical patent/DK0756489T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Cosmetics (AREA)
DK95920275T 1994-06-01 1995-05-19 Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette DK0756489T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19940012288 1994-06-01
PCT/KR1995/000059 WO1995032726A1 (en) 1994-06-01 1995-05-19 Cyclosporin containing composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK0756489T3 true DK0756489T3 (da) 1999-12-06

Family

ID=19384450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920275T DK0756489T3 (da) 1994-06-01 1995-05-19 Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette

Country Status (13)

Country Link
US (1) US5739105A (da)
EP (1) EP0756489B1 (da)
JP (1) JP2936209B2 (da)
KR (1) KR0163212B1 (da)
CN (1) CN1148224C (da)
AT (1) ATE183398T1 (da)
AU (1) AU2577295A (da)
DE (1) DE69511539T2 (da)
DK (1) DK0756489T3 (da)
ES (1) ES2137516T3 (da)
GR (1) GR3031568T3 (da)
RU (1) RU2119351C1 (da)
WO (1) WO1995032726A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618952D0 (en) * 1996-09-11 1996-10-23 Sandoz Ltd Process
KR100241652B1 (ko) * 1997-07-07 2000-03-02 김충섭 이푸리플라본의 경구 투여용 제제의 제조 방법
US6201165B1 (en) 1997-10-16 2001-03-13 Board Of Regents, University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
NZ512599A (en) 1998-12-30 2003-10-31 Dexcel Ltd Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
WO2000040220A1 (en) * 1999-01-06 2000-07-13 Korea Research Institute Of Chemical Technology Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
ES2206363T3 (es) * 2000-04-07 2004-05-16 Laboratoire Medidom S.A. Formulaciones oftalmicas a base de ciclosporina, de acido hialuronico y de polisorbato.
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
JP2005506990A (ja) * 2001-10-19 2005-03-10 アイソテクニカ インコーポレーテッド 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
EP2340789B1 (en) 2005-02-02 2013-05-01 Ossur HF Methods and systems for gathering information regarding a prosthetic foot
GB0921528D0 (en) 2009-12-09 2010-01-27 Mast Carbon Internat Ltd Carbon and its use in blood cleansing applications
JP6200698B2 (ja) * 2013-06-18 2017-09-20 ニュートリー株式会社 嚥下造影検査食
JP2023548966A (ja) * 2020-11-09 2023-11-21 スカイ・セラピューティクス・カンパニー・リミテッド 固相のシクロスポリンａ及びこれを含む分散組成物
CN116406256A (zh) * 2020-11-09 2023-07-07 思凯制药有限公司 固体物质和包含其的分散组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807505D0 (en) * 1988-03-29 1988-05-05 Glaxo Group Ltd Pharmaceutical combinations

Also Published As

Publication number Publication date
EP0756489A1 (en) 1997-02-05
RU2119351C1 (ru) 1998-09-27
GR3031568T3 (en) 2000-01-31
CN1148224C (zh) 2004-05-05
DE69511539D1 (de) 1999-09-23
US5739105A (en) 1998-04-14
WO1995032726A1 (en) 1995-12-07
JPH09510733A (ja) 1997-10-28
ATE183398T1 (de) 1999-09-15
ES2137516T3 (es) 1999-12-16
KR960000247A (ko) 1996-01-25
KR0163212B1 (ko) 1998-12-01
CN1149834A (zh) 1997-05-14
DE69511539T2 (de) 2000-03-30
AU2577295A (en) 1995-12-21
EP0756489B1 (en) 1999-08-18
JP2936209B2 (ja) 1999-08-23

Similar Documents

Publication Publication Date Title
DK0756489T3 (da) Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette
SE9604793D0 (sv) New polymorphs
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
RS49611B (sr) Ziprasidon formulacije
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
DK0775018T4 (da) Fremgangsmåde til fremstilling af katalysatorer af cobalt på aluminiumoxid
HUT74474A (en) Pharmaceutical emulsion comprising a short acting dihydropyridine type antihypertensive agent
BG103384A (en) Halogenpyrimidinylaryl (thio)ethers as pesticides
MX9302380A (es) Receptor de llamada selectiva.
GB0011203D0 (en) Chemical compounds
CA2185541A1 (en) Cytotoxic t-cell epitopes
HK1043809A1 (en) Pharmaceutical composition for treating papillomavirus tumours and infection.
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
GB9126725D0 (en) Process
TW284777B (da)
ES8406439A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
EP0297378A3 (de) 2,5-Dihydropyrrole
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
MY104979A (en) [ 5(6)(ih-azole-1-ylmethyl) benzimidazole] carbamates.
ES8107192A1 (es) Un procedimiento para la preparacion de un compuesto sele- ccionado entre el grupo formado por una imidazolilurea
FR2693746B1 (fr) Compositions a base de cire et contenant des agents tensio-actifs amphoteres, leur preparation et leur utilisation comme agents de finissage.
HUP9702480A3 (en) New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same
IL139604A0 (en) Novel peptides
ZA966749B (en) Endoparasiticidal compositions based on didepsipeptides, new didepsipeptides and processes for their preparation.
DK0937094T3 (da) Fremgangsmåde til fremstilling af ivermectin